Stentless bioprostheses: a versatile and durable solution in extensive aortic valve endocarditis

European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
Adriaan W SchneiderJ Braun

Abstract

Infective endocarditis of the aortic valve with local aortic root destruction requires radical resection of infected tissues and subsequent reconstruction of periannular structures and the left ventricular outflow tract (LVOT). Homografts or stentless bioprostheses are recommended for use in this specific patient group. The Freestyle stentless bioprosthesis is a porcine aortic root prosthesis, which approaches the surgical versatility of the homograft, but has the advantage of ready availability and uniform quality. We assessed clinical and echocardiographic outcome following the use of this prosthesis in extensive aortic valve endocarditis. Between June 2000 and December 2014, 55 Freestyle prostheses were implanted for aortic valve endocarditis involving the root in 54 patients (74% male). The mean age at operation was 61 ± 13 years. The mean EuroSCORE II was 20.1 ± 13.5. Twenty-nine (54%) patients had prosthetic valve endocarditis. The median follow-up time after surgery was 3.5 years, ranging from 0 to 15 years. Early and late mortality were 11% (6 patients) and 14% (7 patients), respectively. Estimated overall survival at 1 and 5 years was 83 and 70%, respectively. There was no survival difference between patients with nati...Continue Reading

References

Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J S LiG R Corey
Oct 31, 2007·American Heart Journal·Evelyn E HillMarie-Christine Herregods
Apr 1, 2008·The Journal of Thoracic and Cardiovascular Surgery·Cary W AkinsUNKNOWN Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity
Sep 22, 2009·The Journal of Thoracic and Cardiovascular Surgery·Michele MusciRoland Hetzer
Feb 2, 2010·Journal of the American College of Cardiology·Ismail El-HamamsyMagdi H Yacoub
May 31, 2011·The Annals of Thoracic Surgery·John G ByrneRobert S D Higgins
Oct 30, 2012·Interactive Cardiovascular and Thoracic Surgery·Antonio MiceliMattia Glauber
Jul 16, 2013·The Journal of Thoracic and Cardiovascular Surgery·Anneliese HeinzLudwig C Müller
Apr 15, 2014·The Annals of Thoracic Surgery·Siamak MohammadiFrançois Dagenais
Feb 11, 2015·The Annals of Thoracic Surgery·Willem FlamengBart Meuris

❮ Previous
Next ❯

Citations

May 13, 2017·Interactive Cardiovascular and Thoracic Surgery·Miriam SilaschiOlaf Wendler
Jul 13, 2017·Asian Cardiovascular & Thoracic Annals·Yasser Y HegazyJürgen Ennker
Sep 28, 2017·General Thoracic and Cardiovascular Surgery·Thierry CarrelJürg Schmidli
Aug 20, 2019·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Adriaan W SchneiderJerry Braun
Mar 23, 2017·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Anton TomšicRobert J M Klautz
Jan 13, 2018·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Adriaan W SchneiderJerry Braun
Apr 21, 2018·Journal of Cardiothoracic Surgery·Anna GomesEhsan Natour
Mar 31, 2021·The Thoracic and Cardiovascular Surgeon·Lorenz HansenFriedrich-Christian Rieß
Jul 29, 2021·JTCVS Techniques·Niranjan Hiremath, Gopal Bhatnagar
Jul 29, 2021·JTCVS Techniques·Hani Ali-Ghosh, Clifford William Barlow
May 19, 2020·The Journal of Thoracic and Cardiovascular Surgery·Bo YangG Michael Deeb
Aug 29, 2021·The Journal of Thoracic and Cardiovascular Surgery·Hanna H DagnegårdMorten H Smerup
Sep 22, 2021·Journal of Cardiac Surgery·Antti HuuskonenPeter Raivio
Dec 7, 2021·Interactive Cardiovascular and Thoracic Surgery·Can Gollmann-TepeköylüElfriede Ruttmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

© 2022 Meta ULC. All rights reserved